|
Full Program Title: Case-Based Approached to Targeted Therapy With COTELLIC (cobimetinib) and ZELBORAF (vemurafenib) for BRAF V600E/K Mutation-Positive Unresectable or Metastatic Melanoma
|
|
6/21/2017
|
|
When:
|
Wednesday, June 21, 2017
6:00 PM
|
|
Where:
|
Fleming's Prime Steakhouse
639 East Shaw Ave.
Fresno, California 93710
United States
|
|
Presenter:
|
Scott Christensen, MD
|
|
|
« Go to Upcoming Event List
|
|
|
Wednesday, June 21th, 2017 at 6:00PM: A Case-Based Approached to Targeted Therapy With COTELLIC (cobimetinib) and ZELBORAF (vemurafenib) for BRAF V600E/K Mutation-Positive Unresectable or Metastatic Melanoma
Location:
Fleming's Prime Steakhouse
639 East Shaw Ave.
Fresno, CA 93710
(559) 222-5823
Presented by:
Scott Christensen, MD
Professor
UC Davis Comprehensive Cancer Center
Sacramento, CA
Hosted by:
Elizabeth Hogan, Program Host, Genentech
(916) 342-3887
RSVP at http://www.medforcereg.net/SGEN7645
Audience Limitation: Please contact program host with for any questions.
Click here to view the Event Flyer
|
|
|
